Evidence map›Paper›PMID 22138824›Full record

ArticleNature methods2011

High-efficiency counterselection recombineering for site-directed mutagenesis in bacterial artificial chromosomes.

Alexander W Bird, Axel Erler, Jun Fu, Jean-Karim Hériché, Marcello Maresca, Youming Zhang, Anthony A Hyman, A Francis Stewart

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Proof of ssDNA degraded from dsDNA for ET recombination.Biochemistry and biophysics reports · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Improved bacterial recombineering by parallelized protein discovery.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Article
  12. Genetic Engineering by DNA Recombineering.Current protocols in chemical biology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Interrogation ofSynthetic and systems biotechnology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander W BirdMax Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. bird@mpi-cbg.de
Axel Erler
Jun Fu
Jean-Karim Hériché
Marcello Maresca
Youming Zhang
Anthony A Hyman
A Francis Stewart

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whereas bacterial artificial chromosomes (BACs) offer many advantages in studies of gene and protein function, generation of seamless, precisely mutated BACs has been difficult. Here we describe a counterselection-based recombineering method and its accompanying reagents. After identifying intramolecular recombination as the major problem in counterselection, we built a strategy to reduce these unwanted events by expressing Redβ alone at the crucial step. We enhanced this method by using phosphothioated oligonucleotides, using a sequence-altered rpsL counterselection gene and developing online software for oligonucleotide design. We illustrated this method by generating transgenic mammalian cell lines carrying small interfering RNA-resistant and point-mutated BAC transgenes. Using this approach, we generated mutated TACC3 transgenes to identify phosphorylation-specific spindle defects after knockdown of endogenous TACC3 expression. Our results highlight the complementary use of precisely mutated BAC transgenes and RNA interference in the study of cell biology at physiological expression levels and regulation.

Indexed as

Cell Line, TumorChromosomes, Artificial, BacterialDrug Resistance, BacterialEscherichia coli ProteinsHumansMicrotubule-Associated ProteinsMutagenesis, Site-DirectedOligonucleotidesProtein EngineeringRecombination, GeneticRibosomal ProteinsRibosomal Protein S9RNA InterferenceSoftwareTransgenesEscherichia coli ProteinsMicrotubule-Associated ProteinsOligonucleotidesRibosomal ProteinsRibosomal Protein S9RpsI protein, E coliRpsL protein, E coliTACC3 protein, human

Identifiers

PMID22138824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.